CBD Guides

CBC vs CBD in the UK: which one for sleep, skin and safety

By the Honest CBD Co team · 16th September 2026 · Updated 24th September 2026

For well-researched systemic support, such as easing anxiety, improving sleep, or managing certain seizure conditions, CBD is the compound with the clinical track record. CBC shows promising early evidence for topical inflammation and skin support, but that evidence is still largely preclinical. Many people get the best of both by choosing a full-spectrum oil from a maker with a track record, since a full-spectrum extract naturally carries a little of each, though safety and dosing deserve a proper look first.

TL;DR:

CBD has a well-established track record for treating conditions like epilepsy, anxiety, sleep issues, and systemic pain, backed by clinical trials.

CBC is mostly found in full-spectrum products and shows early promise for skin health and topical inflammation, but human evidence remains limited.

Both cannabinoids are processed by the liver’s CYP450 system, so they can interact with prescription medicines; the safety section below covers what to check.

Buy from a brand with a track record and compare price per mg of CBD. A full-spectrum oil from an established UK maker is the simplest way to get a little of both cannabinoids.

Starting with a low dose, choosing the right product format, and tracking effects over two to four weeks gives you a fair trial.

Honest CBD Co

Full spectrum CBD made in Bolton since 2018

Honest CBD Co is a husband-and-wife business making small-batch CBD in Bolton since 2018, rated Excellent on Trustpilot across 700+ reviews, with free UK delivery.

Visit Honest CBD Co

CBC vs CBD: what are they and where do you find them?
How do CBC and CBD actually work in the body?
What does the evidence say for pain, inflammation, skin, sleep and neurological use?
Are CBC and CBD safe, and do they interact with medicines?
Should you try CBC, CBD, or both?
How do you choose a safe, reliable CBC or CBD product?
Our take: don’t overthink the choice
Honest CBD Co: full-spectrum CBD made in Bolton since 2018, without the inflated price tag
Sources
FAQ

CBC vs CBD: what are they and where do you find them?

CBD, or cannabidiol, is a non-intoxicating cannabinoid found in relatively high concentrations in hemp. CBC, or cannabichromene, is also non-intoxicating but occurs naturally in much smaller amounts. Neither will get you high; that’s down to THC, a different cannabinoid entirely.

You’ll rarely find CBC sold on its own. Full-spectrum hemp extracts usually carry it as a minor cannabinoid alongside CBD, CBG, and trace CBN, and product surveys confirm that CBC concentrations tend to stay low compared with CBD, with most CBC-specific claims resting on animal and cell-based studies rather than human trials. CBD, by contrast, is widely available as an isolate, meaning you can buy it stripped of every other cannabinoid if you prefer.

Both compounds turn up in similar product formats, though the two aren’t always interchangeable in how they’re used:

Oils and tinctures. The most common way to take either cannabinoid systemically, dropped under the tongue for reasonably quick absorption.
Capsules. A fixed, consistent dose with no measuring, useful if you want to avoid guesswork.
Topical balms and salves. Where CBC’s local anti-inflammatory promise is most often put to use, applied directly to the skin or a sore joint.
Paste. A concentrated option for people who want higher potency without a large volume of liquid.

If you’re buying a full-spectrum oil, you’re very likely getting some CBC whether the label shouts about it or not. It’s the CBD that dominates the profile, and the CBC that rides along as a supporting player. Our own Full Spectrum CBD Oil (10ml, 1000mg for £25.99) is a good example: the label leads on CBD, and the minor cannabinoids come with it. Whether that pairing does anything extra for you is where the entourage effect comes in, which we’ll unpack shortly.

How do CBC and CBD actually work in the body?

CBD and CBC don’t hit the same biological targets, and that’s the real reason their effects diverge. CBD works mostly indirectly. It inhibits an enzyme called FAAH, which slows the breakdown of your body’s own anandamide (sometimes nicknamed the “bliss molecule”), and it interacts with the 5-HT1A serotonin receptor, which may explain some of its calming reputation. At higher doses, CBD also engages TRPV1, a receptor involved in pain and heat sensing.

CBC takes a different route. It binds only weakly to the CB1 and CB2 cannabinoid receptors, which is part of why it doesn’t produce a high, but it shows notably stronger affinity for TRPV1 and TRPA1, receptors tied to pain signalling and inflammatory response. Like CBD, it also appears to influence anandamide levels, though through a different mechanism.

This receptor split has a practical consequence: dose-response curves aren’t the same shape.

CBD tends to produce a fairly linear response as dose increases.
CBC follows a sigmoidal curve: little happens at low concentrations, then a steep rise, then a plateau, so its effect doesn’t simply climb in a straight line with more of the compound. CBN goes further still, with an inverted-U shape where more can mean less.

In a 2026 study of mouse sensory neurons published in the Journal of Pharmacology and Experimental Therapeutics, 50 µM of CBC produced a larger calcium response (85.5% above baseline) than CBD (70.8%), while CBN produced a much smaller one (33.8%). It’s a dish of neurons rather than a person, but it’s clear evidence that these cannabinoids are doing genuinely different jobs at the cellular level, not just weaker or stronger versions of the same thing.

This is also where the entourage effect gets its scientific footing: the theory that cannabinoids and terpenes working together produce a broader effect than any single compound in isolation. It’s not proven as a universal rule, but the differing receptor targets of CBD and CBC give it a plausible mechanism rather than just marketing flavour.

What does the evidence say for pain, inflammation, skin, sleep and neurological use?

CBD is comfortably ahead of CBC when it comes to human clinical data. CBD has the strongest evidence base of any non-intoxicating cannabinoid for treatment-resistant epilepsy, backed by proper clinical trials, and moderate-quality evidence supports its use for anxiety, sleep, and general pain management. CBC’s evidence, by comparison, is still finding its feet, largely built on animal models and lab studies rather than people.

Here’s how the maturity of the evidence breaks down by use:

Pain. CBD has moderate clinical support for general pain relief. CBC’s pain-related promise comes mainly from its TRPV1/TRPA1 affinity in preclinical work, not human trials.
Inflammation. Both compounds show anti-inflammatory activity in lab studies, but CBC’s local, receptor-driven mechanism has made it a candidate specifically for topical inflammation rather than whole-body use.
Skin and acne. This is CBC’s strongest early lane. Small animal and in vitro studies report anti-inflammatory and antimicrobial effects for CBC in skin models, though human trials remain scarce.
Sleep and anxiety. CBD holds the moderate clinical evidence here; CBC has essentially no dedicated human data for either.
Neuroprotection and seizures. This is where CBD’s evidence is genuinely strong, with clinical trials underpinning its approved use in specific epilepsy syndromes. CBC has no comparable clinical grounding for neurological conditions.

The most honest way to frame CBC right now is as a complementary minor cannabinoid, useful in blended topical or full-spectrum formulations for inflammation and skin support, while systemic CBC use remains investigational rather than established.

The practical takeaway: if you’re chasing something with real clinical weight behind it, particularly for sleep, anxiety, or seizure-related conditions, CBD is the compound with the track record. If your interest is skin or localised inflammation, CBC’s early signals are worth watching, but temper your expectations against the fact that most of that promise still comes from petri dishes and animal studies rather than people like you.

Are CBC and CBD safe, and do they interact with medicines?

CBD’s side-effect profile is reasonably well documented at this point. Common reports include fatigue, changes in appetite, and diarrhoea, and clinical trial data has flagged possible liver enzyme elevations at high doses, particularly when CBD is combined with certain other medications. Read more on the full range of CBD side effects UK consumers should know before starting.

CBC’s safety profile is far less established, and that’s worth taking seriously rather than glossing over. Transcriptomic analysis using liver-cell models has flagged potential hepatotoxicity signals for CBC and CBN that in some analyses appeared stronger than those seen for CBD. The researchers behind that work were clear that this is an early signal calling for further study, not a settled verdict, but it’s a good reason to treat CBC with the same caution you’d apply to any newer compound.

Both cannabinoids are processed by the CYP450 liver enzyme system, the same pathway responsible for metabolising a huge range of prescription medicines, including blood thinners, some antidepressants, and certain epilepsy drugs. That shared pathway means CBD and CBC can, in theory, alter how effectively your body processes other medications.

A few sensible precautions go a long way:

Start with a low dose of either compound and increase gradually rather than jumping in at full strength.
Speak to your GP or pharmacist before combining CBD or CBC with prescribed medicines, especially anything metabolised by the liver.
Buy from a brand with a track record that tells you plainly what is in the product and how strong it is, so you know exactly what you’re taking.
Watch for unusual fatigue, appetite changes, or digestive upset in the first few weeks and stop if anything feels off.

Because dose-response curves for cannabinoids like CBC can plateau, or even turn back on themselves, rather than climbing in a straight line, doubling your dose won’t necessarily double the effect, and it may increase the risk of unwanted reactions instead. Build up slowly and give each new dose a few days before adjusting again.

Should you try CBC, CBD, or both?

Matching the compound to your goal starts with a straightforward checklist. Work through it before you buy anything.

Name your primary goal. Systemic issues such as sleep, anxiety, or general wellbeing point towards CBD. Localised skin irritation or joint inflammation points towards a topical. In practice that means a CBD balm or salve, since CBC is rarely sold on its own in the UK; our CBD Body Salve (500mg in a 50ml tin, £19.99) is THC-free CBD in a handcrafted shea butter, coconut oil and beeswax balm.
Pick your format. Oils and capsules suit systemic goals; balms and salves suit topical ones. Paste is a concentrated oral option for people who already know their level.
Choose a brand with a track record. An established maker who tells you plainly what is in the product, how strong it is and what it costs per mg is a far better guide than a glossy label, particularly for anything containing CBC given its thinner safety data.
Start low. Begin with 10-20mg of CBD a day and hold it for at least a week before stepping up. The FSA advises healthy adults to keep to about 10mg of CBD a day, and that advice is worth knowing, though in our view it’s precautionary rather than a ceiling: the FSA’s own figure was 70mg a day until autumn 2023, clinical research typically uses hundreds of milligrams, and many regular users settle somewhere between 25mg and 100mg or more a day. If capsules suit you better, ours come in 40mg for starting out, 80mg for regular users and 120mg for experienced users who know their level. Build up gradually, and check with your GP or pharmacist first if you take prescription medication or are pregnant or breastfeeding. Our guide to CBD oil strengths and converting percentages to mg per drop is a useful reference here.
Track for two to four weeks. Note the time you take it, the dose, and how you feel, both benefits and side effects, so you can judge whether it’s actually working.

If your issue is topical, reach for a balm or salve first rather than assuming an oral oil will help a localised problem. If it’s systemic, CBD-led oils or capsules make more sense as your starting point. For readers who want both mechanisms working together, a full-spectrum oil is the simplest route, and our piece on whether CBD really has an entourage effect digs into how credible that combined-effect theory really is.

How do you choose a safe, reliable CBC or CBD product?

Start with the brand behind the bottle. An established maker can tell you plainly what is in its products, where the CBD comes from and how strong each format is, and a track record counts for a lot. Independent surveys regularly find potency mismatches in commercial cannabinoid products, which is exactly why a brand’s history matters more than its packaging. We’ve made our own small-batch CBD in Bolton since 2018, we answer our own emails, and we’re rated Excellent on Trustpilot across more than 700 reviews.

Format matters for absorption speed too. Oils tend to act faster than capsules because they can be absorbed sublingually, while topicals work locally and don’t reach the bloodstream in meaningful amounts.

Then compare price per mg of CBD rather than price per bottle. It’s the honest way to judge value, and it makes inflated pricing easy to spot. Our 10% Full Spectrum CBD Oil works out at about 2.6p per mg (1000mg for £25.99), and the 20% bottle (2000mg for £37.99) is cheaper again at under 2p per mg.

A few things that should make you look elsewhere:

Vague strength labelling, such as a percentage with no mg figure, or a price you can’t work out per mg.
A brand with no history you can find, no reviews to speak of, and no way to reach a real person.
Health claims that sound too sweeping, particularly around CBC, given how early the human research still is.

Our take: don’t overthink the choice

If you’re weighing CBC against CBD, start with CBD for anything systemic. It has the clinical backing, particularly for epilepsy, and reasonable support for anxiety, sleep, and pain. CBC’s real promise sits with topical inflammation and skin support, but that promise is still mostly preclinical, so keep your expectations proportionate to the evidence.

Whichever you choose, buy from a maker with a track record and go slowly with dosing, especially given the early liver-enzyme signals flagged for CBC. The product guidance above and the sources below are the next sensible stop.

Richard, Honest CBD Co

Honest CBD Co: full-spectrum CBD made in Bolton since 2018, without the inflated price tag

We started Honest CBD Co in 2018 because too many brands were charging inflated prices for ordinary CBD. We’re a husband-and-wife business in Bolton, we make our own products in small batches, and we’re rated Excellent on Trustpilot across more than 700 reviews. Our CBD is lab-tested at source, and we’re happy to share the certificates of analysis if you’d like to see them.

Our range covers the formats discussed throughout this article:

Full Spectrum CBD Oil in 10ml bottles at 10% (1000mg, £25.99) or 20% (2000mg, £37.99), in organic hemp seed oil, keeping the natural minor cannabinoid profile that full-spectrum extraction preserves.
Full Spectrum CBD Capsules at 40mg, 80mg or 120mg per capsule, from £19.99, for a fixed, no-measuring dose.
Whole Plant CBD Paste in 5ml syringes at 15% (750mg, £17.99) or 30% (1500mg, £29.99) for higher-potency needs, and our 85% CBD Distillate Oil (from £9.99) for those wanting the most concentrated systemic option.
Pure CBD Isolate Oil from £14.99 if you’d rather have zero THC, and our CBD Body Salve (500mg, 50ml, £19.99) for topical use.

Delivery is free across the UK. If you’re ready to try full-spectrum CBD for yourself, the 10% Full Spectrum CBD Oil at £25.99 is the natural place to start; browse the full Honest CBD Co shop and pick the strength that fits your goal.

Sources

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

FAQ

Is CBC or CBD better?

Neither is universally “better”; CBD has stronger clinical evidence for systemic uses like sleep, anxiety, and epilepsy, while CBC shows more early promise for topical inflammation and skin support.

How does CBC make you feel?

CBC isn’t intoxicating and won’t produce a high, since it binds only weakly to CB1 receptors; most people report subtle, localised effects such as reduced inflammation when it’s used topically, though human data on how it feels systemically is limited.

Is CBC or CBD better for pain?

CBD has moderate clinical support for general pain relief, while CBC’s pain-related potential comes from preclinical studies on TRPV1 and TRPA1 receptors, making it a candidate worth watching but not yet clinically proven for pain.

Is CBD or CBG better for you?

This article focuses on CBC and CBD specifically, but generally speaking, the “better” cannabinoid depends entirely on your goal, the quality of the product and the maker behind it, which matter more than chasing whichever minor cannabinoid is trending.